A scientific review of VIP in experimental autoimmune encephalomyelitis (the MS model) identified that VIP administration reduced clinical severity scores by forty–sixty five% across 12 impartial research, with histological Investigation displaying lessened CNS infiltration of Th1 and Th17 cells and enhanced Foxp3+ Tregs during the spinal cord.… Read More